Forums
|
< BACK
|
The Growth in Pharmaceutical Care: Examining Cost, Outcomes and Innovation
(How does the continuing rise in pharmaceutical-based care reshape paradigms, alter care value, and spur new developments?)
Note: Click on name to download Powerpoint presentations.
|
June 27, 2003
Reserve Officers Association Building
One Constitution Avenue NE, Washington, D.C
Moderator: Hon. P.T. Henry Former Assistant Secretary of the Army
|
8:00 AM Coffee
8:30 - 8:45 AM Welcoming remarks
8:45 - 10:15 AM Panel 1: A Changing Care Paradigm
(An examination of reasons for continuing growth of pharmaceutical care)
- Richard Manning, PhD, Director, Economic Policy Analysis, Corporate Policy and Strategic Management, Pfizer Corporate Affairs Division
- Daniel Durham, Deputy Director, Office of Health Policy, Department of Health and Human Services
- Robert Roswell, MD, Under Secretary for Health, Department of Veterans Affairs
- William Winkenwerder, MD, Assistant Secretary of Defense for Health Affairs
10:15 - 10:30 AM Break
10:30 - 11:45 AM Panel 2: Outcomes and Other Yardsticks
(Does pharmaceutical care lower costs, make more care available, improve outcomes, drive research?)
- Mike Valentino, Pharmacy Benefit Consultant, Department of Veterans Affairs
- Joseph Torkildson, MD, Director, Clinical Operations, DoD Pharmacoeconomic Center
- Ernst Berndt, PhD, Professor of Applied Economics, MIT Sloan School of Management
- John Derr, RPh, Director of Strategic Planning, American Health Care Association
11:45 - 12:45 PM Lunch
12:45 - 2:00 PM Panel 3: Outlook for the Future
(How will continued expansion in pharmaceutical care affect care delivery?)
- David J. McIntyre, CEO, TriWest Healthcare Alliance
- John Calfee, PhD, Resident Scholar, American Enterprise Institute
- Cecil B. Wilson, MD, Member, Board of Trustees, American Medical Association
- Jonathan B. Perlin, MD, Deputy Under Secretary for Health, Department of Veterans Affairs
2:00 - 2:15 PM Forum summary
|
Co-sponsored by
|
|